Low expression of MPO was an independent risk factor for CR 1 , OS and PFS in AML patients, which may be a simple and highly significant factor for AML patients when evaluating the therapeutic efficacy and prognosis.
← all excerpts
[Correlation between myeloperoxidase expression and gene alterations and prognosis in acute myeloid leukemia].
1
—
—